Obama says he's ready to sign Medicare doctor payment fix
WASHINGTON (AP) — President Barack Obama says he’s ready to sign good bipartisan legislation to fix Medicare’s doctor payment problem, without endorsing any specific legislation.
Blog
FDA again expands usage of Regeneron eye drug Eylea
(Reuters) – U.S. health regulators on Wednesday approved Regeneron Pharmaceuticals Inc’s big-selling eye drug Eylea to treat diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in adults. The Food and Drug Administration decision marked the fourth approval for Eylea, an injectable medicine sold in partnership with French drugmaker Sanofi. “Today’s approval gives patients with diabetic retinopathy and diabetic macular edema another therapy to treat
A look at some key statistics on rare diseases in the US
The global pharmaceutical industry is make huge investments in treatments for rare diseases, which once drew little interest from major drugmakers. A look at some key statistics on rare diseases:
Science, patients driving rare disease drug research surge
TRENTON, N.J. (AP) — The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits.
Obamacare's Impact on Latino Access to Health Insurance
by Gabriel R. Sanchez, Francisco I. Pedraza and Edward D. Vargas As President Obama’s signature domestic policy achievement, the Affordable Care Act (ACA) faces another test in the upcoming Supreme Court case King v. Burwell. As we await a decision that has huge implications for Obamacare, we take a closer look at whether the ACA has been…
U.S. consumer safety regulators probes Lumber Liquidators laminates
WASHINGTON (Reuters) – The U.S. Consumer Product Safety Commission said on Wednesday it was investigating laminates used by Lumber Liquidators Holdings Inc, after reports that its products contained too-high levels of formaldehyde. Commission Chairman Elliot Kaye said the regulator would determine in the coming months whether the products were harmful to human health. He said the company had been cooperative so far with the agency’s probe. (Reporting by Emily Stephenson;
Fighters target vital water plants across Middle East: Red Cross
By Stephanie Nebehay GENEVA (Reuters) – Fighters are increasingly targeting water and sanitation facilities across the Middle East, exacerbating severe shortages for agriculture and households, the International Committee of the Red Cross (ICRC) said on Wednesday. Militants in Syria, Iraq and Gaza have also used access to water and electricity supplies as “tactical weapons or as bargaining chips,” the ICRC said in a report. “Heavy fighting and direct targeting have
New Ebola trial vaccine 'safe': researchers
The latest in a string of candidate vaccines against the deadly Ebola virus was proven safe in an early trial in healthy adults in China, its developers said Wednesday. Dubbed Ad5-EBOV, the vaccine is the first based on the strain of the Ebola virus behind the west African outbreak, according to a paper published in The Lancet medical journal. “Up to now, all tested Ebola virus vaccines have been based
I Have OCD. Here's What It's Like To Be Me For 3 Minutes.
Here’s what it really feels like to live with Obsessive Compulsive Disorder.
Were We Getting Alzheimer’s Wrong? New Study Could Pave Way To Better Treatment
A large Mayo Clinic study has found that, when it comes to what causes Alzheimer’s Disease, researchers may have been barking up the wrong tree.